Company: SMNR
Filing Date: 2025-07-02
Form Type: S-4/A
Source: 0001193125-25-154936
Chunk: 684

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-07-02
Form: S-4/A
Chunk 684
---
 Semnur and its stockholders. In addition, a stockholder’s investment may be adversely affected to the extent New Semnur pay the costs of settlement and damage awards against directors and officers pursuant to these indemnification provisions.

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors or executive officers, New Semnur has been informed that in the opinion of the SEC, such indemnification is against public policy and is therefore unenforceable.

#### Conflicts of Interest
Delaware law permits corporations to adopt provisions renouncing any interest or expectancy in certain opportunities that are presented to the corporation or its officers, directors or stockholders. The Proposed Charter will provide that, to the fullest extent permitted by law, no Identified Person (as defined therein) will have any duty to refrain from (i) engaging in a corporate opportunity in the same or similar business activities or lines of business in which New Semnur or its affiliates are engaged or that are deemed to be competing with New Semnur or any of its affiliates or (ii) otherwise investing in or providing services to any person that is engaged in the same or similar business activities as New Semnur or its affiliates or competes with New Semnur or its affiliates. In addition, to the fullest extent permitted by law, no Identified Person will have any obligation to offer to New Semnur or its subsidiaries or affiliates the right to participate in any corporate opportunity in the same or similar business activities or lines of business in which New Semnur or its affiliates are engaged or that are deemed to be competing with New Semnur or any of its affiliates. Subject to the preceding sentences and to the fullest extent permitted by applicable law, neither New Semnur nor any of its subsidiaries shall have any rights in any business interests, activities or ventures of any Identified Person, and New Semnur waives and renounces

<div align='center'>417</div>

any interest or expectancy therein, except with respect to opportunities offered solely and expressly to officers of New Semnur in their capacity as such.

#### Rights of Appraisal and Payment
Under the DGCL, with certain exceptions, New Semnur’s stockholders will have appraisal rights in connection with a merger or consolidation of New Semnur. Pursuant to Section 262 of the DGCL, stockholders who properly demand and perfect appraisal rights in connection with such merger or consolidation will have the right to receive payment of the fair value of their shares as determined by the Delaware Court of